Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pimodivir on OC PK in Healthy Females
NCT02652650Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pimodivir in Influenza A (IAV), sponsored by Janssen Pharmaceutical. Primary endpoints: Observed Analyte Concentration Just Prior to the Beginning or at the End of a Dosing Interval, Observed Analyte Concentration at 12 Hours Post Dosing and 10 more. Started Dec 2015; status: completed.
02
Drugs
pimodivir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02652650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02652650.